Editorial | Published:

Broader and deeper

Nature Genetics volume 45, page 227 (2013) | Download Citation

Subjects

Cancer genomes are now rapidly yielding to analysis, showing the heterogeneity of the mutational events and processes contributing to disease. This diversity is enormous and occurs at many levels. Consequently, the first clues from exome sequencing will increasingly need to be complemented by integrated analyses and extended to implicate mutations relevant to treatment outcomes.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/ng.2580

Authors

    Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing